Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Brian Boyarsky"'
Autor:
Giuseppe Cullaro, Elizabeth C. Verna, Andres Duarte‐Rojo, Matthew R. Kappus, Daniel R. Ganger, Robert S. Rahimi, Brian Boyarsky, Dorry L. Segev, Mara McAdams‐DeMarco, Daniela P. Ladner, Michael L. Volk, Chi‐yuan Hsu, Jennifer C. Lai
Publikováno v:
Hepatology Communications, Vol 6, Iss 4, Pp 910-919 (2022)
Acute kidney injury (AKI) and frailty are major drivers of outcomes among patients with cirrhosis. What is unknown is the impact of physical frailty on the development of AKI. We included adults with cirrhosis without hepatocellular carcinoma listed
Externí odkaz:
https://doaj.org/article/bbcd459b5c404dc0977494528c4458ec
Autor:
Shivani S. Bisen, BA, Laura B. Zeiser, ScM, Brian Boyarsky, MD, PhD, William Werbel, MD, Jon Snyder, PhD, Jacqueline Garonzik-Wang, MD, PhD, Macey L. Levan, JD, PhD, Dorry L. Segev, MD, PhD, Allan B. Massie, PhD, MHS
Publikováno v:
Transplantation Direct, Vol 9, Iss 1, p e1423 (2023)
Background. Following the outbreak of coronavirus disease 2019 (COVID-19) in the United States, the number of kidney waitlist additions and living-donor and deceased-donor kidney transplants (LDKT/DDKT) decreased substantially but began recovering wi
Externí odkaz:
https://doaj.org/article/f9dde4b28f194b8aa6494840f39f6f2f
Autor:
Afrah S. Sait, MD, Teresa Po-Yu Chiang, MD, MPH, Kieren A. Marr, MD, MBA, Allan B. Massie, PhD, Willa Cochran, CRNP, Pali Shah, MD, Daniel C. Brennan, MD, Alvin G. Thomas, MS, Seema Mehta Steinke, MD, MS, Nitipong Permpalung, MD, MPH, Shmuel Shoham, MD, Christian Merlo, MD, Tania Jain, MD, Brian Boyarsky, MD, Olga Charnaya, MD, Ahmet Gurakar, MD, Kavita Sharma, MD, Christine M. Durand, MD, William A. Werbel, MD, Chiung-Yu Huang, PhD, Darin Ostrander, PhD, Niraj Desai, MD, Min Young Kim, MD, Sami Alasfar, MD, Evan M. Bloch, MD, PhD, Aaron A.R. Tobian, MD PhD, Jacqueline Garonzik-Wang, MD, PhD, Dorry L. Segev, MD, PhD, Robin K. Avery, MD
Publikováno v:
Transplantation Direct, Vol 8, Iss 1, p e1268 (2022)
Background. Few reports have focused on newer coronavirus disease 2019 (COVID-19) therapies (remdesivir, dexamethasone, and convalescent plasma) in solid organ transplant recipients; concerns had been raised regarding possible adverse impact on allog
Externí odkaz:
https://doaj.org/article/d43f8a7fd91142afa711d1b861dece4a
Autor:
Kednapa Thavorn, Dorry L Segev, Teresa Po-Yu Chiang, Allan Massie, Shaifali Sandal, Brian Boyarsky, Marcelo Cantarovich
Publikováno v:
BMJ Open, Vol 12, Iss 1 (2022)
Externí odkaz:
https://doaj.org/article/66dca15353e74fff92eed96896bae21f
Autor:
Shivani S. Bisen, Laura B. Zeiser, Brian Boyarsky, William Werbel, Jon Snyder, Jacqueline Garonzik-Wang, Macey L. Levan, Dorry L. Segev, Allan B. Massie
Publikováno v:
Transplantation direct. 9(1)
Following the outbreak of coronavirus disease 2019 (COVID-19) in the United States, the number of kidney waitlist additions and living-donor and deceased-donor kidney transplants (LDKT/DDKT) decreased substantially but began recovering within a few m
Autor:
Jennifer C, Lai, Amy M, Shui, Andres, Duarte-Rojo, Robert S, Rahimi, Daniel R, Ganger, Elizabeth C, Verna, Michael L, Volk, Matthew, Kappus, Daniela P, Ladner, Brian, Boyarsky, Dorry L, Segev, Ying, Gao, Chiung-Yu, Huang, Jonathan P, Singer
Publikováno v:
JAMA Surgery. 158:130
ImportanceFrailty has been recognized as a risk factor for mortality after liver transplant (LT) but little is known of its association with functional status and health-related quality of life (HRQL), termed global functional health, in LT recipient
Autor:
Shivani Bisen, Brian Boyarsky, William Werbel, Jon Snyder, Laura B. Zeiser, Jacqueline Garonzik-Wang, Macey L. Levan, Dorry L. Segev, Allan B. Massie
Publikováno v:
Transplantation. 106:S222-S222
Autor:
Elizabeth A Thompson, Katerina Roznik, Andrew Karaba, Katherine Cascino, Santosh Dhakal, Laura Sena, Luca Biavatti, Aura T Abedon, Jennifer L Alejo, Sabra L. Klein, Daniel Warren, Caroline X Quin, Jonathan Mitchel, Jacqueline Garonzik-Wang, Robert Leone, Brian Boyarsky, Dorry L Segev, Aaron A.R. Tobian, William Werbel, Andrea L. Cox, Justin R Bailey
Publikováno v:
The Journal of Immunology. 208:65.08-65.08
Solid organ transplant recipients (SOTRs) demonstrate reduced seroconversion and increased breakthrough infection rates following standard two dose mRNA vaccination against SARs-CoV-2. However, within a prospective cohort of SOTRs, the majority of pa
Autor:
Afrah S. Sait, Teresa Po-Yu Chiang, Kieren A. Marr, Allan B. Massie, Willa Cochran, Pali Shah, Daniel C. Brennan, Alvin G. Thomas, Seema Mehta Steinke, Nitipong Permpalung, Shmuel Shoham, Christian Merlo, Tania Jain, Brian Boyarsky, Olga Charnaya, Ahmet Gurakar, Kavita Sharma, Christine M. Durand, William A. Werbel, Chiung-Yu Huang, Darin Ostrander, Niraj Desai, Min Young Kim, Sami Alasfar, Evan M. Bloch, Aaron A.R. Tobian, Jacqueline Garonzik-Wang, Dorry L. Segev, Robin K. Avery
Publikováno v:
Transplantation Direct
Transplantation Direct, Vol 8, Iss 1, p e1268 (2022)
Transplantation Direct, Vol 8, Iss 1, p e1268 (2022)
Supplemental Digital Content is available in the text.
Background. Few reports have focused on newer coronavirus disease 2019 (COVID-19) therapies (remdesivir, dexamethasone, and convalescent plasma) in solid organ transplant recipients; concern
Background. Few reports have focused on newer coronavirus disease 2019 (COVID-19) therapies (remdesivir, dexamethasone, and convalescent plasma) in solid organ transplant recipients; concern